Document ID: chunk:federal_register_of_legislation:F2025L00212:clause:1_188
Version: federal_register_of_legislation:F2025L00212
Segment Type: clause
Provision Reference: sch 1 cl 188
Character Range: 110074–111344

188                                       3'-SIALYLLACTOSE SODIUM                                                           A         Lactose and sodium are mandatory components of 3'-sialyllactose sodium.

                                                                                                                                      The route of administration for medicines that contain 3'-sialyllactose sodium must be limited to oral.

                                                                                                                                      The maximum recommended daily dose of the medicine must not provide more than:

                                                                                                                                      (a) 0.2 g 3'-sialyllactose sodium in infants under 12 months;

                                                                                                                                      (b) 0.15 g 3'-sialyllactose sodium in children aged 12-35 months; or

                                                                                                                                      (c) 0.5 g 3'-sialyllactose sodium in individuals aged 3 years and older.